pneumonia: Last News

Medivir and SciLifeLab partner to identify Covid-19 drug candidates

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Swedish drug development company Medivir has partnered with SciLifeLab, a life science research firm, to identify compounds with the potential to inhibit SARS-CoV-2, the novel coronavirus that causes Covid-19. The research collaboration will involve SciLifeLab’s Drug Discovery and Development Platform (DDD), which will gain access to Medivir’s protease-targeted compound library.

As part of the collaboration, the partners will work to identify the main protease of SARS CoV-2, Mpro, an essential non-structural protein needed for virus replication. DDD will analyse Medivir’s protease-targeted compound library to find putative

. virus covid-19 pneumonia reports

pneumonia: Main News

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Swedish drug development company Medivir has partnered with SciLifeLab, a life science research firm, to identify compounds with the potential to inhibit SARS-CoV-2, the novel coronavirus that causes Covid-19. The research collaboration will involve SciLifeLab’s Drug Discovery and Development Platform (DDD), which will gain access to Medivir’s protease-targeted compound library.

Related News

Breaking news
COVID-19 positivity rate has declined from 30 pc to 10 pc in Delhi: Centre
Pandemic tops 11.5 million cases, imperils HIV care
Home sales down, prices up in Hamilton, Burlington amid pandemic in June: RAHB